Skip Navigation



Carcinogenesis Advance Access published online on January 9, 2006
Carcinogenesis, doi:10.1093/carcin/bgi324
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
27/5/1054    most recent
bgi324v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Li, Z.
Right arrow Articles by Efstratiadis, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Z.
Right arrow Articles by Efstratiadis, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
Received October 3, 2005
Revised December 6, 2005
Accepted December 17, 2005

CARCINOGENESIS

Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene

Zhe Li 1, Matthias Szabolcs 2, Joseph D. Terwilliger 3, and Argiris Efstratiadis 4 *

1 Department of Genetics and Development, Columbia University, New York, NY 10032, USA
2 Department of Pathology, Columbia University, New York, NY 10032, USA
3 Department of Genetics and Development, Columbia University, New York, NY 10032, USA; Department of Psychiatry, Columbia University, New York, NY 10032, USA; Genome Center, Columbia University, New York, NY 10032, USA
4 Department of Genetics and Development, Columbia University, New York, NY 10032, USA; Institute for Cancer Genetics, Columbia University, New York, NY 10032, USA

* To whom correspondence should be addressed.
Argiris Efstratiadis, E-mail: ae4{at}columbia.edu


  Abstract

NEU (ERBB2) and other members of the epidermal growth factor receptor (EGFR) family have been implicated in human prostate cancer (CAP) development and progression to an androgen-independent state, but the extent of involvement and precise role of this signaling pathway remain unclear. To begin addressing such open questions in an animal model, we have developed a transgenic line in which an oncogenic Neu cDNA (Neu*) driven by the probasin gene promoter is overexpressed in the mouse prostate and causes development of prostatic intraepithelial neoplasia (PIN) that progresses to invasive carcinoma. Expression profiling using microarrays, which was selectively validated and extended by immunophenotyping of Neu*-induced PIN and CAP, led to the identification of some novel biomarkers and also revealed increased expression of Egfr, Erbb3 and phosphorylated androgen receptor. In view of this information from our mouse model, which can be used to analyze further the role of Erbb signaling in prostatic tumorigenesis, we examined human prostate cancer tissue arrays by immunohistochemistry. Based on statistical analyses of the results, we propose the testable hypothesis that ERBB3, shown to be expressed in 86% of the human CAP cases that we examined, is the pivotal element of the Erbb pathway promoting tumorigenesis by heterodimerization with NEU or EGFR, whereas a NEU/EGFR dimer does not appear to play a significant role in CAP.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Physiol. GenomicsHome page
H. Zhang, X. Chen, W. B. Bollag, R. J. Bollag, D. J. Sheehan, and C. S. Chew
Lasp1 gene disruption is linked to enhanced cell migration and tumor formation
Physiol Genomics, August 7, 2009; 38(3): 372 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J.-C. Pignon, B. Koopmansch, G. Nolens, L. Delacroix, D. Waltregny, and R. Winkler
Androgen Receptor Controls EGFR and ERBB2 Gene Expression at Different Levels in Prostate Cancer Cell Lines
Cancer Res., April 1, 2009; 69(7): 2941 - 2949.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Casimiro, O. Rodriguez, L. Pootrakul, M. Aventian, N. Lushina, C. Cromelin, G. Ferzli, K. Johnson, S. Fricke, F. Diba, et al.
ErbB-2 Induces the Cyclin D1 Gene in Prostate Epithelial Cells In vitro and In vivo
Cancer Res., May 1, 2007; 67(9): 4364 - 4372.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Priolo, D. Tang, M. Brahamandan, B. Benassi, E. Sicinska, S. Ogino, A. Farsetti, A. Porrello, S. Finn, J. Zimmermann, et al.
The Isopeptidase USP2a Protects Human Prostate Cancer from Apoptosis.
Cancer Res., September 1, 2006; 66(17): 8625 - 8632.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.